Moreover, miR-34a can reduce the activation of STAT3 in p53-deficient CRC cells by decreasing the expression of PPP1R11, and ultimately inhibit EMT and metastasis of CRC cells (Li et al., 2017a). This evidence concerns the gene PPP1R11 and colorectal carcinoma.